Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Molecular biology of infectious agents in chronic arthritis
Rheumatic Disease Clinics of North America, 06/01/09
Gérard HC et al. – Article reviews the molecular biology of the organisms that elicit reactive arthritis, with emphasis on C trachomatis and C pneumoniae, and discusses the means by which those detailed characteristics engender inflammatory joint disease. All currently available data indicate that persistent chlamydial infection of the synovium is a central facet of the arthritogenic process. Whereas there are the beginnings of an understanding of the biology of persistence for C trachomatis, and to a lesser extent for C pneumoniae, there is little information concerning how that infection state is elicited within monocytic cells. Directions for further research that should point the way toward new and effective therapies to treat this form of arthritis are suggested.
Today in Infectious Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Rheumatoid Arthritis and Tuberculous Arthritis: Differentiating MRI Features
American Journal of Roentgenology, 10/26/09
CD23 mediates anti-mycobacterial activity of human macrophages
Infection and Immunity, 10/20/09
Arthroscopic synovectomy, an alternative in the treatment of brucellar arthritis of the knee with prolonged course. A report of two cases
The Internet Journal of Orthopedic Surgery, 10/12/09
Today in Other Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Follow-up results of 702 patients receiving tumor necrosis factor-alpha antagonists and evaluation of risk of tuberculosis
Rheumatology International, 10/26/09
The beneficial effects of a 3 week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: Results of the STIVEA trial
Annals of Rheumatic Diseases, 10/23/09
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
Annals of Rheumatic Diseases, 10/12/09
Sponsor
Article Search
Sponsor


See Latest Articles


